Skip to content

Cell Source, Inc.: 10-Q filed 2022-12-02

What Cell Source, Inc. reported in its quarterly report filed 2022-12-02 (fiscal Q2 2022): 24 published measures, 76 facts as tagged in accession 0001493152-22-034255.

This filing

Form
10-Q (quarterly report)
Filed
2022-12-02
Fiscal period
fiscal Q2 2022
Accession
0001493152-22-034255 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3044,640USD
At 2021-12-31313,767USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-3010,811,199USD
At 2021-12-3110,139,902USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-30-10,766,559USD
At 2022-03-31-9,997,117USD
At 2021-12-31-9,826,135USD
At 2021-06-30-10,026,910USD
At 2021-03-31-9,038,794USD
At 2020-12-31-7,947,382USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-302,597USD
At 2021-12-3193,095USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,285,594USD91
2022-01-01 to 2022-06-30-2,578,169USD181
2021-04-01 to 2021-06-30-1,313,113USD91
2021-01-01 to 2021-06-30-2,837,854USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-1,328,754USD181
2021-01-01 to 2021-06-30-2,257,576USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,238,256USD181
2021-01-01 to 2021-06-302,097,662USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-33,756,597USD
At 2021-12-31-31,178,428USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3034,438,057shares91
2022-01-01 to 2022-06-3034,419,213shares181
2021-04-01 to 2021-06-3032,663,482shares91
2021-01-01 to 2021-06-3032,610,275shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.04USD/shares91
2022-01-01 to 2022-06-30-0.09USD/shares181
2021-04-01 to 2021-06-30-0.05USD/shares91
2021-01-01 to 2021-06-30-0.1USD/shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-04-01 to 2022-06-3074USD91
2022-01-01 to 2022-06-305,034USD181
2021-04-01 to 2021-06-3045,972USD91
2021-01-01 to 2021-06-30283,744USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,033,877USD91
2022-01-01 to 2022-06-30-2,086,549USD181
2021-04-01 to 2021-06-30-995,099USD91
2021-01-01 to 2021-06-30-2,116,455USD181

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-04-01 to 2022-06-3063,313USD91
2022-01-01 to 2022-06-30111,725USD181
2021-04-01 to 2021-06-30140,305USD91
2021-01-01 to 2021-06-30396,688USD181

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-06-30382,009USD
At 2021-12-31223,041USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,033,877USD91
2022-01-01 to 2022-06-302,086,549USD181
2021-04-01 to 2021-06-30995,099USD91
2021-01-01 to 2021-06-302,116,455USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-30555,010USD91
2022-01-01 to 2022-06-301,019,515USD181
2021-04-01 to 2021-06-30355,051USD91
2021-01-01 to 2021-06-30590,815USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3035,239,669shares
At 2021-12-3134,360,546shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-3022,952,986USD
At 2021-12-3121,316,318USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-301,500,937USD
At 2021-12-311,097,021USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,285,594USD91
2022-01-01 to 2022-03-31-1,292,575USD90
2021-04-01 to 2021-06-30-1,313,113USD91
2021-01-01 to 2021-03-31-1,524,741USD90

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,530,565USD91
2022-01-01 to 2022-06-30-3,148,057USD181
2021-04-01 to 2021-06-30-1,538,986USD91
2021-01-01 to 2021-06-30-3,287,118USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30464,367USD91
2022-01-01 to 2022-06-301,038,034USD181
2021-04-01 to 2021-06-30627,548USD91
2021-01-01 to 2021-06-301,477,665USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-251,717USD91
2022-01-01 to 2022-06-30-491,620USD181
2021-04-01 to 2021-06-30-318,014USD91
2021-01-01 to 2021-06-30-721,399USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30158,968USD181
2021-01-01 to 2021-06-30146,895USD181

Inspect the source

Entity
Cell Source, Inc. / CIK 0001569340
Captured
2026-09-20T09:20:59.488Z
SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))